Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
no adverse event; vaccine overdose; This spontaneous report was received from an employee and refers to a 12-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-Aug-2025, the patient was vaccinated with a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (dose, route of administration, vaccination site, lot # and expiration date were not reported) and with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (dose, route of administration, vaccination site, lot # and expiration date were not reported), both administered for prophylaxis (vaccine overdose). The vaccines were reconstituted with sterile diluent, solution for injection (lot # and expiration date were not reported). The reporter did not have any further information. No additional adverse event (AE) and no product quality complaint (PQC) was noted (no adverse event). Lot # is being requested and will be submitted if received.
sterile diluent